AbbVie India Violates UCPMP, 2024
AbbVie Healthcare India Pvt Ltd has violated the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024, by sponsoring international trips for doctors. UCPMP prohibits offering gifts, financial benefits, or travel to healthcare professionals to ensure ethical industry practices. Despite claiming these actions were industry standards, AbbVie faced scrutiny for not implementing remedial measures. This incident highlights concerns about doctor-pharma relationships and the need for strict enforcement of ethical guidelines to sustain trust in the medical community and ensure fair pharmaceutical marketing practices.
Related Posts
If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.
Responses